It's fair to say that Hexo Corp.'s (NASDAQOTH:HYYDF) fiscal year 2019, which started on Aug. 1, is already the most exciting year ever for the Canadian marijuana grower. Hexo landed a major partnership with Molson Coors Brewing (NYSE:TAP). The company changed its name from Hydropothecary to Hexo. And it began shipping products to serve Canada's recreational marijuana market.

It's easy to forget during turbulent markets that over the long haul, stocks have helped long-term investors create life-changing wealth. Even just using index funds, disciplined investors who've put money to work regularly in the stock market have seen their savings climb dramatically. Those who've identified promising niches of the market have done far better.

Canadian pot stocks have been hitting the skids ever since the adult-use recreational market opened up on Oct. 17. This marked sell-off, though, may have finally created some compelling long-term bargains. OrganiGram Holdings (NASDAQOTH:OGRMF) and Aurora Cannabis Inc. (TSX:ACB) (NYSE:ACB), for instance, have both seen their shares slide in a significant way over the last two weeks of trading. As both of these pot companies are well positioned to become top players in this red-hot industry, though, it might be a good time to consider which of these stocks is the better buy.

Like Godzilla rampaging through a city in a low-budget movie, the market meltdown among marijuana stocks has left plenty of carnage in its wake. Many marijuana stocks plunged 25% or more.

The good news is that in the midst of the mayhem, there are several stocks that look really attractive now. Three that stand out are Constellation Brands (NYSE:STZ), Liberty Health Sciences (NASDAQOTH:LHSIF), and Origin House(NASDAQOTH:ORHOF). Here's why these are three marijuana stocks you might want to buy after the market meltdown.

Although edible marijuana products won’t be legal for a year, Canadians have already seen their dangerous impact on children when misused or not safely stored out of their reach.

In early October, a young child from Vancouver Island was hospitalized for ingesting a marijuana-infused gummy bear that she found in the back seat of a vehicle. Innocently, she consumed what appeared to be candy and had to be rushed to the hospital for medical treatment. Unfortunately, this is not an isolated incident.

For years, Prime Minister Justin Trudeau promised to remove the veil of prohibition on recreational marijuana in Canada. On Oct. 17, following months of debate in the Senate, and additional months spent getting the proper infrastructure in place, Canada became the first industrialized country in the world to legalize adult-use weed, and only the second country in the world, other than Uruguay, to do so.

This monumental shift in cannabis policy in our neighbor to the north is paving the way for billions of dollars in annual added sales, as well as creating plenty of new jobs and tax revenue for the Canadian federal government.

With marijuana now legal in Canada, many people are making their way into the cannabis industry, bringing their skills and training into the budding sector.

And while black market weed has typically been a male-dominated industry, female leaders in legal cannabis say there's no better time for women to get a foothold than now.

Unlike technology, finance, and science — sectors often dominated by men, especially in high-ranking positions — cannabis offers an environment that's very open to women and female perspectives. HuffPost Canada spoke to several female leaders in Canada's cannabis industry, to find out how women are being embraced and if opportunities exist to break "the grass ceiling."

There's good news and bad news when it comes to Tilray (NASDAQ:TLRY) and CannTrust Holdings(NASDAQOTH:CNTTF). First, the bad news: Both Canadian marijuana stocks have tanked over the last couple of weeks. The good news, though, is that Tilray and CannTrust are still up a lot so far in 2018.

Tilray has been the bigger winner by far. But which of these two marijuana stocks is the better pick now? Here's how Tilray and CannTrust compare.

You won't find a lot in common between Aurora Cannabis (NYSE:ACB) and MariMed(NASDAQOTH:MRMD).

They both operate in the cannabis industry, but they differ in multiple ways, including geographical focus, size, and stock performance.

On the last category, MariMed has been the clear winner so far in 2018.

Its stock has more than quintupled while Aurora's share price is close to where it started the year.

But which of these two marijuana stocks is the better pick for investors now? Here's how Aurora Cannabis and MariMed stack up against each other.

Canopy Growth Corporation (NYSE:CGC) and Constellation Brands (NYSE:STZ) are definitely joined at the hip. They're partners with plans to market cannabis-infused beverages. Constellation owns 38% of Canopy thanks to its $4 billion investment in August. But they're still different stocks.

Even with the big pullback over the last couple of weeks, Canopy's share price is still up well over 50% in 2018. Constellation, meanwhile, is down year to date. Which of these stocks is the better buy now?